Trial Profile
AmBisome in Combination With Caspofungin Versus AmBisome High Dose Regimen for the Treatment of Invasive Aspergillosis in Immunocompromized Patients: Randomized Pilot Study.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 15 Jul 2015
Price :
$35
*
At a glance
- Drugs Amphotericin B liposomal (Primary) ; Caspofungin
- Indications Aspergillosis; Invasive bronchopulmonary aspergillosis
- Focus Therapeutic Use
- Acronyms COMBISTRAT
- Sponsors Gilead Sciences
- 15 Jul 2015 New trial record